Furthermore, CRC cells activate NRP-2 in LECs via VEGF-C/VEGFR3 signaling, which is independent of the integrin91/FAK/Erk pathway, to promote tumor lymphangiogenesis. This evidence concerns the gene FLT4 and neoplasm.